Genicular Artery Embolization for the Treatment of Knee Osteoarthritis
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Degenerative Joint Disease of Knee
- Knee Osteoarthritis
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: The stratification will not be randomized, but each category will be limited to 20 patients.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 40 years and 79 years
- Gender
- Both males and females
Description
This is a phase 2, single-center, prospective, single arm investigational study to evaluate the safety and efficacy of genicular artery embolization (GAE) for treatment of symptomatic knee osteoarthritis (OA). Subjects will be treated with a genicular artery embolization (GAE) procedure performed wi...
This is a phase 2, single-center, prospective, single arm investigational study to evaluate the safety and efficacy of genicular artery embolization (GAE) for treatment of symptomatic knee osteoarthritis (OA). Subjects will be treated with a genicular artery embolization (GAE) procedure performed with Embozene Microspheres. The microspheres will be delivered in a saline-contrast medium solution and will be delivered to the arteries supplying the areas of the subject's pain. The primary objective of this investigation is to assess safety of genicular artery embolization (GAE) for knee osteoarthritis (OA) using Embozene particles.
Tracking Information
- NCT #
- NCT03491397
- Collaborators
- Boston Scientific Corporation
- Investigators
- Principal Investigator: Siddharth Padia, M.D. University of California, Los Angeles
Get Well Soon